| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/04/2014 | US8642539 Method for treating a disease characterized by reduced appetite |
| 02/04/2014 | US8642538 Macrocyclic hepatitis C serine protease inhibitors |
| 02/04/2014 | US8642537 Hepatitis B virus-binding polypeptides and methods of use thereof |
| 02/04/2014 | US8642536 Method of making biologically active alpha-beta peptides |
| 02/04/2014 | US8642535 Short fatty acid tail polymyxin derivatives and uses thereof |
| 02/04/2014 | US8642534 Proteins and polynucleotides of Vibrio cholerae |
| 02/04/2014 | US8642533 Methods of nourishing animals |
| 02/04/2014 | US8642532 Excipients for protein stabilization |
| 02/04/2014 | US8642531 Influenza antigen delivery vectors and constructs |
| 02/04/2014 | US8642357 Semaphorin 7A plays a critical role in TGF-β1-induced pulmonary fibrosis and alveolar destruction |
| 02/04/2014 | US8642347 Urinary CA125 peptides as biomarkers of ovarian cancer |
| 02/04/2014 | US8642335 Compositions of active Wnt protein |
| 02/04/2014 | US8642291 Method for producing proteins comprising non-natural amino acids incorporated therein |
| 02/04/2014 | US8642259 Method for identifying substances capable of modulating the activity of a target molecule |
| 02/04/2014 | US8642050 Gonococcal proteins and nucleic acids |
| 02/04/2014 | US8642048 Multiple antigenic peptides immunogenic against Streptococcus pneumonia |
| 02/04/2014 | US8642044 Prevention and treatment of amyloidogenic disease |
| 02/04/2014 | US8642043 Peptide epitopes of apolipoprotein B |
| 02/04/2014 | US8642036 Treatment with anti-ErbB2 antibodies |
| 02/04/2014 | US8642034 Use of TGF-β antagonists to treat infants at risk of developing bronchopulmonary dysplasia |
| 02/04/2014 | US8642030 Compositions containing coenzyme Q-10 and dihydrolipoic acid |
| 02/04/2014 | US8642028 Recombinant adenoviruses encoding the specific iodine transporter (NIS) |
| 02/04/2014 | US8642026 Methods and compositions for contributing to the treatment of cancers |
| 02/04/2014 | US8642025 Hepatitis C virus inhibitors |
| 02/04/2014 | US8642010 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
| 02/04/2014 | CA2727642C Synthesis of cyclosporin analogs |
| 02/04/2014 | CA2706742C Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent |
| 02/04/2014 | CA2706212C Use of alpha-1-antitrypsin for the preparation of drugs for the treatment of chronic fatigue syndrome |
| 02/04/2014 | CA2645550C Use of peptides for the control of radiation injury |
| 02/04/2014 | CA2610948C Compositions and methods for treating diverticular disease |
| 02/04/2014 | CA2543484C Modulation of immune response to an immunogen with ctla-4 and tnfbp |
| 02/04/2014 | CA2539273C A fusion protein comprising an interleukin-1 receptor antagonist and uses thereof |
| 02/04/2014 | CA2453470C Use of follistatin for the treatment of hepatic fibrogenesis |
| 02/04/2014 | CA2442533C A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent |
| 02/04/2014 | CA2432797C Local regional chemotherapy and radiotherapy using in situ hydrogel |
| 02/04/2014 | CA2358860C Dna-binding protein yb-1-containing collagen accumulation inhibitors |
| 02/04/2014 | CA2326388C A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| 02/04/2014 | CA2301879C Tuberculosis vaccine |
| 01/30/2014 | WO2014018931A1 Methods and compositions for treating autoimmune disease |
| 01/30/2014 | WO2014018847A1 Dual cap system for container-closures to maintain tip sterility during shelf storage |
| 01/30/2014 | WO2014018832A1 Genetically modified probiotic for the treatment of phenylketonuria (pku) disease |
| 01/30/2014 | WO2014018807A1 Peptide epoxyketone compounds |
| 01/30/2014 | WO2014018763A2 Method of treating type i diabetes using apolipoprotein aiv |
| 01/30/2014 | WO2014018747A2 Glycoproteins with anti-inflammatory properties |
| 01/30/2014 | WO2014018619A1 Methods and compounds for increasing threonyl-trna synthetase activity |
| 01/30/2014 | WO2014018404A1 Gdf9:bmp15 heterodimers for enhancing fertility |
| 01/30/2014 | WO2014018295A1 Therapeutic anti-virus vlps |
| 01/30/2014 | WO2014018079A1 Method of treating hyperglycemic disorders using apoliprotein aiv |
| 01/30/2014 | WO2014018066A2 Mass production of suspension for treating thrombocytopenia |
| 01/30/2014 | WO2014018018A1 Composition and method for reducing tissue damage from inflammatory disorder or pathogenic infection |
| 01/30/2014 | WO2014017987A1 Method of promoting wound healing |
| 01/30/2014 | WO2014017941A1 Comprehensive promoter and use thereof in cancer gene therapy |
| 01/30/2014 | WO2014017927A1 Method of treating optic nerve damage, ophthalmic ischemia or ophthalmic reperfusion injury |
| 01/30/2014 | WO2014017849A1 A liquid formulation of long-acting insulin and insulinotropic peptide |
| 01/30/2014 | WO2014017847A1 A liquid formulation of long-acting insulin conjugate |
| 01/30/2014 | WO2014017845A2 A liquid formulation of long acting insulinotropic peptide conjugate |
| 01/30/2014 | WO2014017843A1 Composition for treating hyperlipidemia comprising oxyntomodulin derivative |
| 01/30/2014 | WO2014017599A1 Novel t cell epitope peptide of japanese cypress pollen allergen |
| 01/30/2014 | WO2014017570A1 Composition for preventing or treating osteoarthrosis |
| 01/30/2014 | WO2014017474A1 Collagen peptide composition production method, dpp-4 inhibitor, and antihyperglycemic agent |
| 01/30/2014 | WO2014017462A1 Pharmaceutical composition for inhibiting abnormal spine formation |
| 01/30/2014 | WO2014017145A1 Composition |
| 01/30/2014 | WO2014016917A1 Acidic liquid nutrient |
| 01/30/2014 | WO2014016837A1 Compositions and methods for increasing carnitine level in muscle tissues |
| 01/30/2014 | WO2014016831A1 Glutathione-elevating compositions and uses thereof |
| 01/30/2014 | WO2014016829A1 Insoluble fibrinogen particles (ifp) and coatings : composition, fabrication methods, and applications for harvesting and culturing mammalian cells |
| 01/30/2014 | WO2014016683A2 Topical preventative medicament against burns-related systemic inflammatory response syndrome |
| 01/30/2014 | WO2014016613A2 The use of type-b lantibiotic-based compounds having antimicrobial activity |
| 01/30/2014 | WO2014016504A1 System for delivering lectin-based active ingredients |
| 01/30/2014 | WO2014016417A1 Hmgb1 variants and uses thereof |
| 01/30/2014 | WO2014016300A1 Glucagon analogues |
| 01/30/2014 | WO2014016238A1 Compositions for oral administration having a beneficial effect on tendinopathies and ligament injuries |
| 01/30/2014 | WO2014015831A1 Tumor antigenic peptide and application of same as tumor vaccine |
| 01/30/2014 | WO2014015388A1 A method for polishing albumin |
| 01/30/2014 | WO2014003536A9 Dosage regime of fusion compounds |
| 01/30/2014 | WO2013185114A3 Chimeric clotting factors |
| 01/30/2014 | WO2013184986A3 Methods and compositions for inhibiting angiogenesis |
| 01/30/2014 | WO2013184939A3 Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide |
| 01/30/2014 | WO2013184794A3 Peripheral kappa receptor agonists for reducing pain and inflammation |
| 01/30/2014 | WO2013136069A3 Animal feed supplement and assay method |
| 01/30/2014 | US20140031367 Delta opioid receptor agonist compounds |
| 01/30/2014 | US20140031298 Compositions and Methods for Localized Therapy of the Eye |
| 01/30/2014 | US20140031296 New synthetic peptides and their use |
| 01/30/2014 | US20140031295 Recombinant C7 and Methods of Use |
| 01/30/2014 | US20140031293 Therapeutic agents with improved fibrinogen binding |
| 01/30/2014 | US20140031290 Novel glp-1 receptor stabilizers and modulators |
| 01/30/2014 | US20140031288 Novel composition for tumor growth control |
| 01/30/2014 | US20140031287 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (glp-1) compound or a melanocortin-4 receptor (mic4) agonist peptide |
| 01/30/2014 | US20140031286 Angiotensin (1-7) Dosage Forms and Uses Thereof |
| 01/30/2014 | US20140031285 Photodegradable groups for tunable polymeric materials |
| 01/30/2014 | US20140031282 Formulation for treatment of hyperinsulinemic hypoglycemia following gastric bypass surgery |
| 01/30/2014 | US20140031281 Polymer-based sustained release device |
| 01/30/2014 | US20140031280 Methods for preventing and treating post-traumatic stress disorder (ptsd) |
| 01/30/2014 | US20140031278 Novel Glucagon Analogues |
| 01/30/2014 | US20140031277 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/30/2014 | US20140031276 Compounds and methods for preventing or treating a viral infection |
| 01/30/2014 | US20140031274 Biological activity of placental protein 13 |
| 01/30/2014 | US20140030791 Mutant MT-SP1 proteases with altered substrate specificity or activity |
| 01/30/2014 | US20140030347 Mass production of ready-to-use suspensions of fibrinogen-coated albumin spheres for the treatment of thrombocytopenic patients |
| 01/30/2014 | US20140030340 Preparation of drug particles using evaporation precipitation into aqueous solutions |